Liquid chromatography–tandem mass spectrometry (LC–MS/MS) and microbiome data reveal kidney markers of diabetic disease.
News|Videos|October 16, 2026
Conversations with Michael Dong: Overcoming Challenges with Reversed-Phase Chromatography in Drug Analysis
Author(s)Michael W. Dong
In this fifth part of " Conversations with Michael Dong," a series on fundamentals of HPLC in pharmaceutical analysis, LCGC International’s "Perspectives in HPLC" column editor discusses how to overcome challenges with reversed-phase chromatography in drug analysis.
Advertisement
Michael Dong, editor of LCGC International's "Perspectives in HPLC" column, has launched a video series in 2026 called "HPLC in Pharmaceutical Analysis," which explores how the technique is used in the pharmaceutical field.
In celebration of National Chemistry Week at the end of October, ChromatographyOnline.com is pleased to share "Conversations with Michael Dong" this month, featuring highlights from the series. We encourage readers to watch the full series, a free and thorough educational introduction to HPLC for pharmaceutical laboratory professionals at every stage of their careers who want to brush up on the basics. No matter how much experience you have with the technique, you're sure to come away with useful tips for sharpening your skills.
In this installment, Dong discusses how to overcome challenges with reversed-phase chromatography in drug analysis.
The entire video, “Why acid mobile phase A is used in pharmaceutical analysis?” can be accessed at
Previous videos in this series can be accessed here:
Advertisement
Related to this article
Ultrahigh-performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS) shows Maresin1 drops in heatstroke and may protect the heart.
This week on Chromatography Online, leading experts shared practical insights with LCGC International on sustainable affinity methods, siRNA impurity profiling, nontarget screening, peptide tech transfer, and AI in separation science.
Liquid chromatography–mass spectrometry (LC–MS) was used to determine if there is a link between artificial sweeteners and breast cancer.
Chiral gas chromatography–mass spectrometry (GC–MS) shows how heat and storage alter linalool in blueberry juice.
Anneli Kruve reports that toxicity predictions from MS2-derived molecular fingerprints outperform spectral-similarity methods in nontarget screening of food.
In this fourth part of " Conversations with Michael Dong," a series on fundamentals of HPLC in pharmaceutical analysis, LCGC International’s "Perspectives in HPLC" column editor explains why buffers are most often used in Mobile Phase A in high-pressure liquid chromatography of pharmaceuticals.
Skipping solid-phase extraction (SPE) cleanup rarely hurt liquid chromatography–tandem mass spectrometry (LC–MS/MS) plant hormone results in tomato.
Advertisement
Advertisement
Trending on LCGC International
1
Prioritizing Unknowns in Nontarget Screening of Food Samples
2
Conversations with Michael Dong: Buffers for Mobile Phase A in Pharmaceutical Analysis
3
LC–MS Probes Link Between Artificial Sweeteners and Breast Cancer
4
AI ML Now: Gert Desmet on the Future of Artificial Intelligence and Machine Learning in Separation Science
5